3
Announcements
Trials
Browse
Landscape
Sponsor
Conditions
Leukemia, Myelomonocytic, Acute
4
Leukemia, Myeloid, Acute
4
Leukemia, Monocytic, Acute
4
Leukemia, Megakaryoblastic, Acute
4
Leukemia, Erythroblastic, Acute
4
Lymphoma, Non-Hodgkin
3
Wilms Tumor
2
Thyroid Neoplasms
2
Squamous Cell Carcinoma of Head and Neck
2
Sarcoma, Ewing
2
Sarcoma
2
Rhabdomyosarcoma
2
Rhabdoid Tumor
2
Osteosarcoma
2
Neuroectodermal Tumors, Primitive, Peripheral
2
Neuroblastoma
2
Melanoma
2
Medulloblastoma
2
Leukemia, Myelomonocytic, Chronic
2
Histiocytosis, Langerhans-Cell
2
Hepatoblastoma
2
Head and Neck Neoplasms
2
Glioma
2
Glioblastoma
2
Ependymoma
2
Congenital Abnormalities
2
Breast Neoplasms
2
Brain Neoplasms
2
Anemia, Refractory, with Excess of Blasts
2
Xanthogranuloma, Juvenile
1
Interventions
fludarabine phosphate
7
Peripheral Blood Stem Cell Transplantation
7
Whole-Body Irradiation
6
Mycophenolic Acid
6
Cyclosporine
5
Cyclophosphamide
5
Rituximab
4
Tacrolimus
3
Melphalan
3
Busulfan
3
Antilymphocyte Serum
3
Alemtuzumab
3
thymoglobulin
2
fludarabine
2
Thiotepa
2
Radiotherapy
2
Methotrexate
2
Granulocyte Colony-Stimulating Factor
2
Filgrastim
2
Etoposide
2
Darbepoetin alfa
2
Cyclosporins
2
plerixafor
1
merphos
1
ferrous sulfate
1
ferric gluconate
1
blinatumomab
1
Transplantation
1
Therapeutics
1
Sunitinib
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
0 trials
Recent
Start date
Enrollment
Has results
×
Leukemia, Large Granular Lymphocytic
×
tipifarnib
×
Clear all
No trials found.